glp-1 contraindications thyroid What are the for starting Glucagon-like peptide-1 (GLP-1) receptor agonists? Contraindications, warnings, and precautions of

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the treatment of obesity and type 2 diabetes mellitus (T2DM) by mimicking endogenous GLP-1 activity, increasing glucose-dependent insulin secretion and suppressing glucagon release

If weekly dosing, consider holding a week before the procedure

Clinical trials suggest that patients who achieve at least 5% body weight loss by months three to four are likely to be long-term responders

The warning links Ozempic to a condition known as ileus, which can cause abdominal cramps, bloating, nausea, vomiting, constipation, difficulty passing gas and difficulty eating

Retatrutide is especially important because triple agonism may become the next efficacy frontier

*All medication use complies with applicable FDA and state guidelines